This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Feb 14;121(7):1067-8.

doi: 10.1182/blood-2012-12-469965.

UGT2B17 as a disease accelerator in CLL

Yiming Zhong¹, John C Byrd

Affiliations

PMID: 23411731
DOI: 10.1182/blood-2012-12-469965

Free article

Comment

UGT2B17 as a disease accelerator in CLL

Yiming Zhong et al. Blood. 2013.

Free article

. 2013 Feb 14;121(7):1067-8.

doi: 10.1182/blood-2012-12-469965.

Authors

Yiming Zhong¹, John C Byrd

Affiliation

¹ The Ohio State University.

PMID: 23411731
DOI: 10.1182/blood-2012-12-469965

No abstract available

PubMed Disclaimer

Comment on

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.
Gruber M, Bellemare J, Hoermann G, Gleiss A, Porpaczy E, Bilban M, Le T, Zehetmayer S, Mannhalter C, Gaiger A, Shehata M, Fleiss K, Skrabs C, Lévesque É, Vanura K, Guillemette C, Jaeger U. Gruber M, et al. Blood. 2013 Feb 14;121(7):1175-83. doi: 10.1182/blood-2012-08-447359. Epub 2012 Nov 20. Blood. 2013. PMID: 23169782

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

P01 CA081534/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations